نتایج جستجو برای: hypogonadism

تعداد نتایج: 3699  

Journal: :Endokrynologia Polska 2009
Michał Rabijewski Wojciech Zgliczyński

Hypogonadism in men is defined as a complex of signs and symptoms due to testosterone deficiency or inappropriate production, which occurs in about 1-2%. Symptoms of hypogonadism depend primarily on the age of the male patients at the time of development of the hypogonadism (pre- or postpubertal). The dominant findings are: impaired puberty, decrease of virilization, infertility or decrease of ...

Journal: :Journal of Education, Health and Sport 2021

Appropriate concentration of androgens is necessary for general men’s health, especially development and maintain reproductive sexual function, as well metabolic balance. The state deficiency testosterone or its inadequate action, inability to produce good quality semen called hypogonadism. Depending on the function testicles, production sperm also conditioned hypothalamus-pituitary axis, statu...

Journal: :The New England journal of medicine 2007
Taneli Raivio John Falardeau Andrew Dwyer Richard Quinton Frances J Hayes Virginia A Hughes Lindsay W Cole Simon H Pearce Hang Lee Paul Boepple William F Crowley Nelly Pitteloud

BACKGROUND Idiopathic hypogonadotropic hypogonadism, which may be associated with anosmia (the Kallmann syndrome) or with a normal sense of smell, is a treatable form of male infertility caused by a congenital defect in the secretion or action of gonadotropin-releasing hormone (GnRH). Patients have absent or incomplete sexual maturation by the age of 18. Idiopathic hypogonadotropic hypogonadism...

Journal: :Frontiers of hormone research 2009
Stefan Arver Mikael Lehtihet

Hypogonadism in males is a clinical syndrome complex which comprises symptoms with or without signs as well as biochemical evidence of testosterone deficiency. The diagnosis of hypogonadism thus includes both clinical history and examination as well as biochemical assessment of serum testosterone levels. Hypogonadal symptoms depend on the age at onset of hypogonadism, severity of the deficiency...

2016
Sasima Srisukh Boonsong Ongphiphadhanakul Pongamorn Bunnag

Despite recent advances in iron chelation therapy, excess iron deposition in pituitary gonadotropic cells remains one of the major problems in thalassemic patients. Hypogonadism, mostly hypogonadotropic hypogonadism, is usually detected during puberty. Early diagnosis and treatment are crucial for normal pubertal development and to reduce the complications of hypogonadism. The risks and benefit...

Journal: :The Canadian journal of urology 2011
Jack Barkin

Erectile dysfunction (ED) is one of the earliest signs and markers of present or potential future endothelial dysfunction. One of the causes of ED can be low testosterone levels or hypogonadism. This article describes ways to identify and diagnose patients with ED or hypogonadism, and it offers a plan for treatment of these conditions. The mainstay first-line medical therapies for ED are phosph...

2017
Arthi Thirumalai Kathryn E. Berkseth John K. Amory

The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism ...

Journal: :Postgraduate medical journal 1998
G V Gill

A case is presented of a young competitive body-builder who abused anabolic steroid drugs and developed profound symptomatic hypogonadotrophic hypogonadism. With the help of prescribed testosterone (Sustanon) he stopped taking anabolic drugs, and later stopped Sustanon also. Hypogonadism returned, but was successfully treated with weekly injections of human chorionic gonadotropin for three mont...

Journal: :The aging male : the official journal of the International Society for the Study of the Aging Male 2007
Malcolm Carruthers

The diagnosis of late life hypogonadism is controversial. For the purposes of discussion, it is suggested that treatment of late life hypogonadism requires the presence of symptoms, a low level of circulating free or bioavailable testosterone level and a positive response to treatment. While this may appear to be a radical proposal, we believe it represents the most rigorous scientific approach...

Journal: :The Journal of urology 2015
Giulia Rastrelli Emma L Carter Tomas Ahern Joseph D Finn Leen Antonio Terence W O'Neill Gyorgy Bartfai Felipe F Casanueva Gianni Forti Brian Keevil Mario Maggi Aleksander Giwercman Thang S Han Ilpo T Huhtaniemi Krzysztof Kula Michael E J Lean Neil Pendleton Margus Punab Dirk Vanderschueren Frederick C W Wu

CONTEXT Secondary hypogonadism is common in aging men; its natural history and predisposing factors are unclear. OBJECTIVES The objectives were 1) to identify factors that predispose eugonadal men (T ≥ 10.5 nmol/L) to develop biochemical secondary hypogonadism (T < 10.5 nmol/L; LH ≤ 9.4 U/L) and secondary hypogonadal men to recover to eugonadism; and 2) to characterize clinical features assoc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید